用于肿瘤血流临床评估的全面且可重复的超声造影定量方法
该回顾性分析纳入80例肝脏超声造影检查(40例含病灶,主要为肝细胞癌28例),每例至少2次微泡造影剂注射并采集60秒连续图像,评估注射间重复性。拟合曲线与直接计算得到的上升时间和平均通过时间平均注射间变异系数均小于21%,峰值强度和曲线下面积均小于40%;拟合对数正态曲线R²的95%CI为[0.95, 0.96]。
要点
- 拟合曲线与直接计算两种方法得到的灌注参数值无统计学显著差异,仅病灶与肝实质峰值强度及病灶平均通过时间例外。
- 注射间变异系数:上升时间和平均通过时间均小于21%,峰值强度和曲线下面积均小于40%。
- 作者提出采用关节臂固定探头和自动呼吸门控算法以获得可重复的超声造影血流参数。
核心结论
- 该扫描方案与分析方法可对超声造影数据中的病灶血流进行易于重复的定量评估,获得既往无法得到的团注通过参数;拟合曲线与直接计算所得数值及注射间重复性相似,提示可避免曲线拟合以实现更标准化的方法。
研究设计与样本
- 回顾性分析研究,纳入80例肝脏超声造影检查,其中40例含病灶(主要为肝细胞癌,n=28);每例至少2次微泡造影剂注射,每次注射1.2 mL,采集60秒连续图像,采用自动呼吸门控与运动补偿算法处理呼吸运动。
诊断标准与关键数值
- 提取上升时间、平均通过时间、峰值强度和曲线下面积四个团注通过参数,可直接从时间-强度曲线数据或拟合的对数正态分布曲线获得;注射间重复性以变异系数评估;拟合对数正态曲线决定系数R²的95%CI为[0.95, 0.96]作为数据质量指标。
临床应用与阅片要点
- 作者提出探头稳定理想上应使用关节臂、并采用自动呼吸门控算法;作者认为该方法可能有助于临床医生在纵向研究中利用超声造影评估治疗监测中的真实灌注变化。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The aim of this study is to define a comprehensive and repeatable contrast-enhanced ultrasound (CEUS) imaging protocol and analysis method to quantitatively assess lesional blood flow. Easily repeatable CEUS evaluations are essential for longitudinal treatment monitoring. The quantification method described here aims to provide a structure for future clinical studies.
MATERIALS AND METHODS: This retrospective analysis study included liver CEUS studies in 80 patients, 40 of which contained lesions (primarily hepatocellular carcinoma, n = 28). Each patient was given at least 2 injections of a microbubble contrast agent, and 60-second continuous loops were acquired for each injection to enable evaluation of repeatability. For each bolus injection, 1.2 mL of contrast was delivered, whereas continuous, stationary scanning was performed. Automated respiratory gating and motion compensation algorithms dealt with breathing motion. Similar in size regions of interest were drawn around the lesion and liver parenchyma, and time-intensity curves (TICs) with linearized image data were generated. Four bolus transit parameters, rise time ( RT ), mean transit time ( MTT ), peak intensity ( PI ), and area under the curve ( AUC ), were extracted either directly from the actual TIC data or from a lognormal distribution curve fitted to the TIC. Interinjection repeatability for each parameter was evaluated with coefficient of variation. A 95% confidence interval was calculated for all fitted lognormal distribution curve coefficient of determination ( R2 ) values, which serves as a data quality metric. One-sample t tests were performed between values obtained from injection pairs and between the fitted lognormal distribution curve and direct extraction from the TIC calculation methods to establish there were no significant differences between injections and measurement precision, respectively.
RESULTS: Average interinjection coefficient of variation with both the fitted curve and direct calculation of RT and MTT was less than 21%, whereas PI and AUC were less than 40% for lesion and parenchyma regions of interest. The 95% confidence interval for the R2 value of all fitted lognormal curves was [0.95, 0.96]. The 1-sample t test for interinjection value difference showed no significant differences, indicating there was no relationship between the order of the repeated bolus injections and the resulting parameters. The 1-sample t test between the values from the fitted lognormal distribution curve and the direct extraction from the TIC calculation found no statistically significant differences (α = 0.05) for all perfusion-related parameters except lesion and parenchyma PI and lesion MTT .
CONCLUSIONS: The scanning protocol and analysis method outlined and validated in this study provide easily repeatable quantitative evaluations of lesional blood flow with bolus transit parameters in CEUS data that were not available before. With vital features such as probe stabilization ideally performed with an articulated arm and an automated respiratory gating algorithm, we were able to achieve interinjection repeatability of blood flow parameters that are comparable or surpass levels currently established for clinical 2D CEUS scans. Similar values and interinjection repeatability were achieved between calculations from a fitted curve or directly from the data. This demonstrated not only the strength of the protocol to generate TICs with minimal noise, but also suggests that curve fitting might be avoided for a more standardized approach. Utilizing the imaging protocol and analysis method defined in this study, we aim for this methodology to potentially assist clinicians to assess true perfusion changes for treatment monitoring with CEUS in longitudinal studies.
引用
- Krolak C, Wei A, Shumaker M, et al. A Comprehensive and Repeatable Contrast-Enhanced Ultrasound Quantification Approach for Clinical Evaluations of Tumor Blood Flow. Invest Radiol. 2024. PMID: 39418656. doi:10.1097/RLI.0000000000001127
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。